-->

Support for earlier studies on efficacy of OTC mouthwashes against SARS-CoV2

Organisation: Position: Deadline Date: Location:

An over-the-counter mouthwash can kill SARS-CoV2 within 30 seconds of being exposed to it, found a Cardiff University in vitro study

The preliminary result comes ahead of a clinical trial into whether using over-the-counter mouthwash could to reduce the levels of Covid-19 in a patient’s saliva. Two earlier preliminary studies using very small numbers of patients with COVID19 have suggested that cetypyridinium chloride-based mouthwashes may reduce SARS-CoV2 loads in vivo.

The Cardiff University report said that mouthwashes containing at least 0.07 per cent cetypyridinium chloride (CPC) showed “promising signs” of combatting the virus. The report is yet to be peer reviewed.

The latest test was carried out by scientists at the university’s laboratory and mimicked the conditions of a person’s naso/oropharynx passage using various mouthwash brands, including Dentyl and Listerine.

A clinical trial will next examine how effective mouthwash is in reducing the viral load in the saliva of Covid-19 patients at the University Hospital of Wales in Cardiff, with its results due to be published in the first part of 2021.

Abstract

The ability of widely-available mouthwashes to inactivate SARS-CoV-2 in vitro was tested using a protocol capable of detecting a 5-log10 reduction in infectivity, under conditions mimicking the naso/oropharynx. During a 30 second exposure, two rinses containing cetylpyridinium chloride and a third with ethanol/ethyl lauroyl arginate eliminated live virus to EN14476 standards (>4-log10 reduction), while others with ethanol/essential oils and povidone-iodine (PVP-I) eliminated virus by 2-3-log10. Chlorhexidine or ethanol alone had little or no ability to inactivate virus in this assay. Studies are warranted to determine whether these formulations can inactivate virus in the human oropharynx in vivo, and whether this might impact transmission.

 

Full BioRxiv report (Open Access)(Not peer reviewed)

 

See also:

 

MedicalBrief Archives: Some OTC mouthwashes neutralise human coronaviruses

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.